Search Page

1

Cite

Share

Isolated Colonic Post-Transplantation Lymphoproliferative Disease.

Fredrick T, Piovezani Ramos G, Loftus EV Jr. Fredrick T, et al. Among authors: loftus ev jr. Clin Gastroenterol Hepatol. 2021 Jan 29:S1542-3565(21)00091-4. doi: 10.1016/j.cgh.2021.01.041. Online ahead of print. Clin Gastroenterol Hepatol. 2021. PMID: 33516951 No abstract available.

Cite

Share

2

Cite

Share

Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.

Sinh P, Tabibian JH, Biyani PS, Mehta K, Mansoor E, Loftus EV Jr, Dave M. Sinh P, et al. Among authors: loftus ev jr. Dig Dis Sci. 2021 Jan 25. doi: 10.1007/s10620-020-06818-x. Online ahead of print. Dig Dis Sci. 2021. PMID: 33492533

Cite

Share

3

Cite

Share

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting.

Siegel CA, Melmed GY, McGovern DP, Rai V, Krammer F, Rubin DT, Abreu MT, Dubinsky MC; International Organization for the Study of Inflammatory Bowel Disease (IOIBD); International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). Siegel CA, et al. Gut. 2021 Apr;70(4):635-640. doi: 10.1136/gutjnl-2020-324000. Epub 2021 Jan 20. Gut. 2021. PMID: 33472895 Free PMC article. No abstract available.

Cite

Share

4

Cite

Share

Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.

Le Berre C, Peyrin-Biroulet L; SPIRIT-IOIBD study group. Le Berre C, et al. Gastroenterology. 2021 Jan 6:S0016-5085(21)00016-0. doi: 10.1053/j.gastro.2020.10.065. Online ahead of print. Gastroenterology. 2021. PMID: 33421515

Cite

Share

5

Cite

Share

Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.

Azzam N, AlRuthia Y, Alharbi O, Aljebreen A, Almadi M, Loftus EV Jr. Azzam N, et al. Among authors: loftus ev jr. Hepatol Int. 2020 Dec;14(6):1114-1124. doi: 10.1007/s12072-020-10110-5. Epub 2020 Dec 28. Hepatol Int. 2020. PMID: 33369708

Cite

Share

6

Cite

Share

Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme.

Winthrop KL, Loftus EV Jr, Baumgart DC, Reinisch W, Nduaka CI, Lawendy N, Chan G, Mundayat R, Friedman GS, Salese L, Thorpe AJ, Su C. Winthrop KL, et al. Among authors: loftus ev jr. J Crohns Colitis. 2020 Nov 27:jjaa233. doi: 10.1093/ecco-jcc/jjaa233. Online ahead of print. J Crohns Colitis. 2020. PMID: 33245746

Cite

Share

7

Cite

Share

Nonbiologic Immune Suppression in Ulcerative Colitis.

Heron V, Loftus EV Jr. Heron V, et al. Among authors: loftus ev jr. Gastroenterol Clin North Am. 2020 Dec;49(4):731-738. doi: 10.1016/j.gtc.2020.07.003. Epub 2020 Sep 19. Gastroenterol Clin North Am. 2020. PMID: 33121692 Review.

Cite

Share

8

Cite

Share

Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases.

Barnes EL, Loftus EV Jr, Kappelman MD. Barnes EL, et al. Among authors: loftus ev jr. Gastroenterology. 2021 Feb;160(3):677-689. doi: 10.1053/j.gastro.2020.08.064. Epub 2020 Oct 21. Gastroenterology. 2021. PMID: 33098884 Review.

Cite

Share

9

Cite

Share

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis.

Lukin D, Faleck D, Xu R, Zhang Y, Weiss A, Aniwan S, Kadire S, Tran G, Rahal M, Winters A, Chablaney S, Koliani-Pace JL, Meserve J, Campbell JP, Kochhar G, Bohm M, Varma S, Fischer M, Boland B, Singh S, Hirten R, Ungaro R, Lasch K, Shmidt E, Jairath V, Hudesman D, Chang S, Swaminath A, Shen B, Kane S, Loftus EV Jr, Sands BE, Colombel JF, Siegel CA, Sandborn WJ, Dulai PS. Lukin D, et al. Among authors: loftus ev jr. Clin Gastroenterol Hepatol. 2020 Oct 8:S1542-3565(20)31388-4. doi: 10.1016/j.cgh.2020.10.003. Online ahead of print. Clin Gastroenterol Hepatol. 2020. PMID: 33039584 Free article.

Cite

Share

10

Cite

Share

Long-term safety of vedolizumab for inflammatory bowel disease.

Loftus EV Jr, Feagan BG, Panaccione R, Colombel JF, Sandborn WJ, Sands BE, Danese S, D'Haens G, Rubin DT, Shafran I, Parfionovas A, Rogers R, Lirio RA, Vermeire S. Loftus EV Jr, et al. Aliment Pharmacol Ther. 2020 Oct;52(8):1353-1365. doi: 10.1111/apt.16060. Epub 2020 Sep 2. Aliment Pharmacol Ther. 2020. PMID: 32876349 Free PMC article. Clinical Trial.

Cite

Share